Caitong International Asset Management Co., Ltd
Position in AGIO — Agios Pharmaceuticals, Inc.
CIK 1963355
HONG KONG, K3
Position in AGIO
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$548,790
+$365,328 QoQ
Shares Held
16,222
+140.7% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AGIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Caitong International Asset Management Co., Ltd holds $19,465,367 across 279 Biotechnology names. AGIO ranks #7 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
55,071 | $2,797,606 | |
| 2 | WVE |
Wave Life Sciences Ltd.
|
180,980 | $1,312,105 | |
| 3 | VRDN |
Viridian Therapeutics, Inc.\DE
|
64,980 | $1,271,008 | |
| 4 | ADMA |
Adma Biologics, Inc.
|
112,937 | $1,017,562 | |
| 5 | SRRK |
Scholar Rock Holding Corp
|
18,173 | $893,384 | |
| 6 | SNDX |
Syndax Pharmaceuticals Inc
|
33,197 | $775,481 | |
| 7 | AGIO |
Agios Pharmaceuticals, Inc.
This page
|
16,222 | $548,790 | |
| 8 | MAZE |
Maze Therapeutics, Inc.
|
17,783 | $530,822 |
All Filings in AGIO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $548,790 | 16,222 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $183,462 | 6,740 | Shares | Sole | 2026-03-04 | |
| 2025-06-30 | $698 | 21 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $1,318 | 45 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $24,940 | 759 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||